Vineet Laboratories [VINEETLAB] vs Nippon Life India [NAM] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Vineet Laboratories Ltd. wins in 9 metrics, Nippon Life India Asset Management Limited wins in 10 metrics, with 0 ties. Nippon Life India Asset Management Limited appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Vineet Laboratories Ltd. | Nippon Life India Asset Management Limited | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 316.25 | 186.84 | Nippon Life India Asset Management Limited |
| Price-to-Book Ratio | 2.62 | 3.31 | Vineet Laboratories Ltd. |
| Debt-to-Equity Ratio | 300.83 | 1.70 | Nippon Life India Asset Management Limited |
| PEG Ratio | -2.69 | -5.61 | Vineet Laboratories Ltd. |
| EV/EBITDA | -21.30 | 48.03 | Nippon Life India Asset Management Limited |
| Profit Margin (TTM) | -18.10% | 0.53% | Nippon Life India Asset Management Limited |
| Operating Margin (TTM) | 12.19% | 0.71% | Vineet Laboratories Ltd. |
| EBITDA Margin (TTM) | 12.19% | 0.71% | Vineet Laboratories Ltd. |
| Return on Equity | -137.85% | 3.14% | Nippon Life India Asset Management Limited |
| Return on Assets (TTM) | -21.36% | 3.01% | Nippon Life India Asset Management Limited |
| Free Cash Flow (TTM) | $104.46M | $-8.13M | Vineet Laboratories Ltd. |
| 1-Year Return | 13.23% | 1.28% | Vineet Laboratories Ltd. |
| Price-to-Sales Ratio (TTM) | 1.37 | 1.01 | Nippon Life India Asset Management Limited |
| Enterprise Value | $783.83M | $306.80M | Vineet Laboratories Ltd. |
| EV/Revenue Ratio | 1.40 | 0.81 | Nippon Life India Asset Management Limited |
| Gross Profit Margin (TTM) | 37.50% | 1.95% | Vineet Laboratories Ltd. |
| Revenue per Share (TTM) | $61 | $70 | Nippon Life India Asset Management Limited |
| Earnings per Share (Diluted) | $-7.50 | $0.38 | Nippon Life India Asset Management Limited |
| Beta (Stock Volatility) | -0.16 | 0.23 | Vineet Laboratories Ltd. |
Vineet Laboratories Ltd. vs Nippon Life India Asset Management Limited Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Vineet Laboratories Ltd. | 0.09% | 1.83% | -0.79% | 13.94% | -20.15% | -5.21% |
| Nippon Life India Asset Management Limited | -4.75% | 0.08% | -9.29% | -10.65% | -17.67% | -5.95% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Vineet Laboratories Ltd. | 13.23% | -34.42% | -36.39% | -36.39% | -36.39% | -36.39% |
| Nippon Life India Asset Management Limited | 1.28% | 43.62% | 102.29% | 130.39% | 395.16% | 395.16% |
Performance & Financial Health Analysis: Vineet Laboratories Ltd. vs Nippon Life India Asset Management Limited
| Metric | VINEETLAB | NAM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹796.10M | ₹402.03M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 140,288 | 335 |
| 90 Day Avg. Volume | 112,817 | 321 |
| Last Close | ₹34.00 | ₹79.00 |
| 52 Week Range | ₹27.96 - ₹49.99 | ₹68.00 - ₹105.30 |
| % from 52W High | -31.99% | -24.98% |
| All-Time High | ₹124.00 (Jul 12, 2021) | ₹198.00 (Sep 02, 2024) |
| % from All-Time High | -72.58% | -60.10% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.13% | 0.03% |
| Quarterly Earnings Growth | -0.14% | -0.36% |
| Financial Health | ||
| Profit Margin (TTM) | -0.18% | 0.01% |
| Operating Margin (TTM) | 0.12% | 0.01% |
| Return on Equity (TTM) | -1.38% | 0.03% |
| Debt to Equity (MRQ) | 300.83 | 1.70 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹15.25 | ₹21.47 |
| Cash per Share (MRQ) | ₹0.71 | ₹13.23 |
| Operating Cash Flow (TTM) | ₹76.58M | ₹16.34M |
| Levered Free Cash Flow (TTM) | ₹-201,910,000 | ₹3.57M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | ₹0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Vineet Laboratories Ltd. vs Nippon Life India Asset Management Limited
| Metric | VINEETLAB (Apr 24, 2026) | NAM (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 316.25 | 186.84 |
| Forward P/E | N/A | N/A |
| PEG Ratio | -2.69 | -5.61 |
| Price to Sales (TTM) | 1.37 | 1.01 |
| Price to Book (MRQ) | 2.62 | 3.31 |
| Market Capitalization | ||
| Market Capitalization | ₹796.10M | ₹402.03M |
| Enterprise Value | ₹783.83M | ₹306.80M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.40 | 0.81 |
| Enterprise to EBITDA | -21.30 | 48.03 |
| Risk & Other Metrics | ||
| Beta | -0.16 | 0.23 |
| Book Value per Share (MRQ) | ₹15.25 | ₹21.47 |
Financial Statements Comparison: Vineet Laboratories Ltd. vs Nippon Life India Asset Management Limited
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | VINEETLAB (2025) | NAM (2025) |
|---|---|---|
| Revenue/Sales | 749.95M | 666.09M |
| Cost of Goods Sold | 719.14M | 652.72M |
| COGS % of Revenue | 95.9% | 98.0% |
| Gross Profit | 30.81M | 13.38M |
| Gross Margin | 4.1% | 2.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | -187.85M | 3.95M |
| Operating Margin | -25.0% | 0.6% |
| EBITDA | -163.68M | 6.39M |
| EBITDA Margin | -21.8% | 1.0% |
| Pre-Tax Income | -207.76M | 4.77M |
| Pre-Tax Income % of Revenue | -27.7% | 0.7% |
| Income Tax | -5.85M | 1.20M |
| Income Tax % of Revenue | -0.8% | 0.2% |
| Net Income (Profit) | -201.91M | 3.57M |
| Profit Margin | -26.9% | 0.5% |
Balance Sheet & Liquidity Metrics
| Metric | VINEETLAB (2025) | NAM (2025) |
|---|---|---|
| Cash & Equivalents | 3.07M | 1.50M |
| Total Current Assets | 673.94M | 94.28M |
| Total Current Assets % of Revenue | 89.9% | 14.2% |
| Total Current Liabilities | 743.89M | 3.96M |
| Total Current Liabilities % of Revenue | 99.2% | 0.6% |
| Long-Term Debt | 37.86M | 0 |
| Long-Term Debt % of Revenue | 5.0% | 0.0% |
| Total Shareholders Equity | 146.48M | 113.51M |
| Retained Earnings | -59.24M | 29.69M |
| Retained Earnings % of Revenue | -7.9% | 4.5% |
| Property, Plant & Equipment | 18.29M | 24.14M |
Cash Flow Statement Comparison
| Metric | VINEETLAB (2025) | NAM (2025) |
|---|---|---|
| Operating Cash Flow | 76.58M | 16.34M |
| Operating Cash Flow % of Revenue | 10.2% | 2.5% |
| Capital Expenditures | -10.45M | -19.06M |
| Free Cash Flow | 104.46M | -8.13M |
| FCF Margin | 13.9% | -1.2% |
| Debt Repayment | -44.52M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VINEETLAB | NAM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 19.21M | 5.39M |
| Float Shares | 6.68M | 389,137 |
| % Held by Insiders | 14.31% | 90.00% |
| % Held by Institutions | 0.00% | 0.00% |
| % Held by Public | 85.69% | 10.00% |
Dividend Analysis & Yield Comparison: Vineet Laboratories Ltd. vs Nippon Life India Asset Management Limited
| Metric | VINEETLAB | NAM |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | ₹0.33 | N/A |
| 3-Year Avg Dividend Yield | 1.64% | N/A |
| 3-Year Total Dividends | ₹1.00 | N/A |
| Ex-Dividend Date | Sep 19, 2022 | N/A |